Prognostic factors in influenza-associated encephalopathy

Pediatric Infectious Disease Journal

Volumn 27, Issue 5, 2008, Pages 384-389

  Nagao, Takashi ^a   Morishima, Tsuneo ^a   Kimura, Hiroshi ^b   Yokota, Syumpei ^c   Yamashita, Nobuko ^a   Ichiyama, Takashi ^d   Kurihara, Mana ^e   Miyazaki, Chiaki ^f   Okabe, Nobuhiko ^g  

^a OKAYAMA UNIVERSITY   (Japan)

^b NAGOYA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^c YOKOHAMA CITY UNIVERSITY   (Japan)

^d YAMAGUCHI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^e KANAGAWA REHABILITATION CENTER   (Japan)

^f Fukuoka Center for Handicapped Children   (Japan)

^g NATIONAL INSTITUTE OF INFECTIOUS DISEASES   (Japan)

Author keywords

diclofenac; hypercytokinemia; IL 6; nfluenza associated encephalopathy; TNF

Indexed keywords

ASPARTATE AMINOTRANSFERASE; DICLOFENAC; MEFENAMIC ACID; PARACETAMOL;

ADOLESCENT; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; BRAIN DISEASE; CHILD; DEATH; FEMALE; HEMATURIA; HUMAN; HYPERGLYCEMIA; INFLUENZA; MAJOR CLINICAL STUDY; MALE; PREDICTION; PRIORITY JOURNAL; PROGNOSIS; PROTEINURIA; SURVIVAL; BLOOD; INFANT; JAPAN; MORTALITY; MULTIVARIATE ANALYSIS; NEWBORN; PRESCHOOL CHILD; RETROSPECTIVE STUDY; RISK FACTOR; STATISTICAL MODEL; VIROLOGY;

ADOLESCENT; ASPARTATE AMINOTRANSFERASES; BRAIN DISEASES; CHILD; CHILD, PRESCHOOL; DICLOFENAC; FEMALE; HEMATURIA; HUMANS; HYPERGLYCEMIA; INFANT; INFANT, NEWBORN; INFLUENZA, HUMAN; JAPAN; LOGISTIC MODELS; MALE; MULTIVARIATE ANALYSIS; PROGNOSIS; PROTEINURIA; RETROSPECTIVE STUDIES; RISK FACTORS;

EID: 45849097283     PISSN: 08913668     EISSN: 15320987     Source Type: Journal    
DOI: 10.1097/INF.0b013e318162a13b     Document Type: Article

References (22)

1. Morishima T, Togashi T, Yokota S, et al. Encephalitis and encephalopathy associated with an influenza epidemic in Japan. Clin Infect Dis. 2002;35:512-517.
2. Bhat N, Wright JG, Broder KR, et al. Influenza-associated deaths among children in the United States, 2003-2004. N Engl J Med. 2005;353: 2559-2567.
3. Steininger C, Popow-Kraupp T, Laferl H, et al. Acute encephalopathy associated with influenza A virus infection. Clin Infect Dis. 2003;36: 567-574.
4. Hall SM. Reye's syndrome and aspirin: a review. J R Soc Med. 1986;79:596 -598.
5. Belay ED, Bresee JS, Holman RC, et al. Reye's syndrome in the United States from 1981 through 1997. N Engl J Med. 1999;340:1377-1382.
6. Kawashima H, Togashi T, Yamanaka G, et al. Efficacy of plasma exchange and methylprednisolone pulse therapy on influenza-associated encephalopathy. J Infect. 2005;51:E53-E56.
7. Munakata M, Kato R, Yokoyama H, et al. Combined therapy with hypothermia and anticytokine agents in influenza A encephalopathy. Brain Dev. 2000;22:373-377.
8. Ichiyama T, Morishima T, Isumi H, et al. Analysis of cytokine levels and NF-kappaB activation in peripheral blood mononuclear cells in influenza virus-associated encephalopathy. Cytokine. 2004;27:31-37.
9. Ito Y, Ichiyama T, Kimura H, et al. Detection of influenza virus RNA by reverse transcription-PCR and proinflammatory cytokines in influenzavirus- associated encephalopathy. J Med Virol. 1999;58:420-425.
10. Kawada J, Kimura H, Ito Y, et al. Systemic cytokine responses in patients with influenza-associated encephalopathy. J Infect Dis. 2003; 188:690-698.
11. Nunoi H, Mercado MR, Mizukami T, et al. Apoptosis under hypercytokinemia is a possible pathogenesis in influenza-associated encephalopathy. Pediatr Int. 2005;47:175-179.
12. Ichiyama T, Isumi H, Ozawa H, et al. Cerebrospinal fluid and serum levels of cytokines and soluble tumor necrosis factor receptor in influenza virusassociated encephalopathy. Scand J Infect Dis. 2003;35:59-61.
13. Yokota S, Imagawa T, Miyamae T, et al. Hypothetical pathophysiology of acute encephalopathy and encephalitis related to influenza virus infection and hypothermia therapy. Pediatr Int. 2000;42:197-203.
14. Watanabe T, Okazaki E, Shibuya H. Influenza A virus-associated encephalopathy with haemophagocytic syndrome. Eur J Pediatr. 2003; 162:799-800.
15. Harnish MJ, Lange T, Dimitrov S, et al. Differential regulation of human blood glucose level by interleukin-2 and -6. Exp Clin Endocrinol Diabetes. 2005;113:43- 48.
16. Tsigos C, Papanicolaou DA, Kyrou I, et al. Dose-dependent effects of recombinant human interleukin-6 on glucose regulation. J Clin Endocrinol Metab. 1997;82:4167- 4170.
17. Glasgow JF, Middleton B. Reye syndrome-insights on causation and prognosis. Arch Dis Child. 2001;85:351-353.
18. Maheady DC. Reye's syndrome: review and update. J Pediatr Health Care. 1989;3:246 -250
19. Bzduch V, Behulova D, Salingova A, et al. Serum free carnitine in medium chain acyl-CoA dehydrogenase deficiency. Bratisl Lek Listy. 2003;104:405- 407.
20. Bzduch V, Behulova D, Lehnert W, et al. Metabolic cause of Reye-like syndrome. Bratisl Lek Listy. 2001;102:427- 429.
21. Chen Y, Mizuguchi H, Yao D, et al. Thermolabile phenotype of carnitine palmitoyltransferase II variations as a predisposing factor for influenza-associated encephalopathy. FEBS Lett. 2005;579:2040 -2044.
22. Fukuda M, Kitaichi K, Abe F, et al. Altered brain penetration of diclofenac and mefenamic acid, but not acetaminophen, in Shiga-like toxin II-treated mice. J Pharmacol Sci. 2005;97:525-532.